The Role of Stem Cell Transplant in Plasma Cell Leukemia

Name: The Role of Stem Cell Transplant in Plasma Cell Leukemia
Start: 2023-02-01T13:00:00-05:00
End: 2023-02-01T14:00:00-05:00

Feb 01, 2023

01:00PM - 02:00PM EST

Online Event

Overview

We are extremely pleased to announce that PCL specialist, Dr. Wilson Gonsalves from Mayo Clinic in Rochester will be joining us to speak on the role of Stem Cell Transplant in Plasma Cell Leukemia. Even if you have had a transplant, please join us to learn and ask Dr. Gonsalves your PCL-based questions. He is really looking forward to meeting you!

Agenda

01:00 PM

Introductions

Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Stephanie Wiese.

01:05 PM

Presentation

Dr. Wilson Gonsalves

Dr. Gonsalves talks about the role of Stem Cell Transplant in Plasma Cell Leukemia.

01:35 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

Speakers & Moderators

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Dr. Wilson Gonsalves

All cancers have altered cellular metabolism to keep up with their energy and nutrient requirements because of their uncontrolled proliferation. Wilson I. Gonsalves, M.D., researches the cellular metabolism of malignant plasma cells in diseases such as multiple myeloma by employing a variety of systems biology techniques in an integrated fashion. As a result, Dr. Gonsalves' laboratory aims to exploit the unique metabolic features of malignant plasma cells for diagnostic and therapeutic purposes. Dr. Gonsalves serves as the principal investigator for several early-phase clinical trials that investigate the safety and efficacy of novel compounds that disrupt the activity of select metabolic pathways in myeloma cells in patients.